Radiobiological evaluation of the therapeutic effect of silver-111 for the ISOLPHARM project

Introduction:The ISOLPHARM project has the aim of developing novel radiopharmaceuticals using the wide choice of radionuclides produced by Isotope Separation OnLine (ISOL) at LNL-INFN in the SPES facility, which is currently nearing completion. One of the most promising candidates for Targeted Radio...

Descripció completa

Dades bibliogràfiques

Autors principals:	Alberto Arzenton, Aurora Leso, Francesca Rana, Giulia S. Valli, Elena Delgrosso, Laura Cansolino, Cinzia Ferrari, Silva Bortolussi, Isabella Guardamagna, Giorgio Baiocco, Giorgio Grosso, Davide Serafini, Andrea Gandini, Valerio Di Marco, Antonietta Donzella, Emilio Mariotti, Marcello Lunardon, Devid Maniglio, Germano Bonomi, Alberto Andrighetto
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-03-01
Col·lecció:	Frontiers in Nuclear Medicine
Matèries:	clonogenic survival foci ISOLPHARM linear quadratic model micronuclei radiobiology
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fnume.2026.1773638/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!